Esperion Therapeutics: Q2 Earnings Snapshot
ANN ARBOR, Mich. (AP) — ANN ARBOR, Mich. (AP) — Esperion Therapeutics Inc. (ESPR) on Tuesday reported a loss of $49.9 million in its second quarter.
On a per-share basis, the Ann Arbor, Michigan-based company said it had a loss of 46 cents.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 63 cents per share.
The biopharmaceutical company posted revenue of $25.8 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $25.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR
